Yield10 Bioscience Inc expected to post a loss of 56  cents a share - Earnings Preview

Yield10 Bioscience

08/05/2021 02:05

* Yield10 Bioscience Inc  YTEN.OQ   YTEN.O  is expected to show
a rise in quarterly revenue when it reports results on May 11 .
* The Woburn, Massachusetts-based company is expected to report 
 a 21.8% increase in revenue to $218 thousand from $179 thousand
a year ago, according to the mean estimate from 2 analysts,
based on Refinitiv data. 
​* Refinitiv's mean analyst estimate for Yield10 Bioscience Inc
is for a loss of 56 cents per share. For the same quarter last
year, the company reported a loss of $2.12 per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Yield10
Bioscience Inc is $25​, about 56.7% above​ its last closing
price of $10.83. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Dec. 31 2020              -0.70      -0.79     Missed  -13.3
 Sep. 30 2020  -0.95       -0.94      -0.87     Beat    7.9
 Jun. 30 2020  -1.30       -1.30      -1.09     Beat    16.2​
 Mar. 31 2020  -2.13       -1.97      -2.12     Missed  -7.6
 Dec.          -4.59​      -4.00      -0.02     Beat    99.5​
 31​ 2019​                                              
 Sep. 30 2019  -6.67       -6.60      -6.40     Beat    3​
 Jun. 30 2019  -8.57       -8.40      -6.00     Beat    28.6
 Mar. 31 2019  -9.22       -9.20      -8.80     Beat    4.3
 This summary was machine generated May 8 at 01:05 GMT.  All
figures in US dollars unless otherwise stated